159P COM701 in combination with nivolumab demonstrates preliminary antitumor activity in patients with platinum-resistant epithelial ovarian cancer. (December 2022) - Yeku, O.; D. Shepard; Patel, M.; Fleming, G.; Vaena, D.; Rasco, D.; Chmielowski, B.; Sharma, M.R.; Hamilton, E.; Sullivan, R.J.; Papadopoulos, K.; Izar, B.; et al.